GAIL (India) Limited (GAILF)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	13,142	14,085	14,288	8,419	9,107	8,224
Market Cap Growth	-15.51%	-1.42%	69.71%	-7.56%	10.74%	79.37%
Enterprise Value	15,333	16,032	16,153	9,989	9,855	8,667
Last Close Price	10.80	10.80	12.81	6.73	7.29	6.32
PE Ratio	9.69	9.67	12.03	12.31	5.64	9.81
PS Ratio	0.79	0.85	0.89	0.48	0.75	1.05
PB Ratio	1.32	1.41	1.54	1.06	1.08	1.13
P/TBV Ratio	1.38	1.47	1.61	1.11	1.12	1.18
P/FCF Ratio	-	15.42	1407.95	-	28.23	18.25
P/OCF Ratio	-	7.65	9.46	21.57	7.34	6.69
EV/Sales Ratio	0.94	0.97	1.01	0.56	0.81	1.11
EV/EBITDA Ratio	8.28	8.88	9.69	11.18	4.97	8.72
EV/EBIT Ratio	11.03	11.78	12.21	16.42	5.80	12.04
EV/FCF Ratio	-	17.55	1591.80	-	30.54	19.24
Debt / Equity Ratio	0.25	0.25	0.28	0.27	0.14	0.15
Debt / EBITDA Ratio	1.47	1.40	1.48	2.29	0.60	1.06
Debt / FCF Ratio	-	2.77	257.76	-	3.76	2.39
Asset Turnover	-	1.10	1.15	1.43	1.05	0.74
Inventory Turnover	-	18.94	18.27	27.27	21.53	14.17
Quick Ratio	-	0.56	0.61	0.61	0.74	0.57
Current Ratio	-	0.98	0.94	0.95	1.08	0.89
Return on Equity (ROE)	-	15.35%	13.92%	8.65%	20.93%	11.97%
Return on Assets (ROA)	-	5.64%	5.92%	3.06%	9.08%	4.22%
Return on Capital (ROIC)	6.48%	7.07%	7.57%	3.99%	11.97%	5.61%
Return on Capital Employed (ROCE)	-	10.50%	10.70%	5.80%	15.80%	7.70%
Earnings Yield	10.32%	10.35%	8.32%	8.12%	17.73%	10.20%
FCF Yield	-	6.49%	0.07%	-8.14%	3.54%	5.48%
Dividend Yield	3.52%	0.81%	0.52%	0.72%	1.21%	0.72%
Payout Ratio	-	34.34%	36.57%	54.65%	32.60%	36.47%
Buyback Yield / Dilution	-0.02%	-0.03%	0.29%	1.00%	1.50%	0.04%
Total Shareholder Return	3.49%	0.79%	0.80%	1.72%	2.71%	0.76%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.